PDF Version SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering pursuant to Fluidigm’s existing shelf registration statement. In connection with... Read more
Stakes Claim in Emerging Spatial Genomics Space PLEASANTON, CA.—December 10, 2018—10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight... Read more
10 DEC 2018 | DARMSTADT, GERMANY genOway to acquire exclusive rights to Merck’s foundational genome-editing patents to produce, sell rodent models New technologies and solutions to be developed using CRISPR/Cas9 to accelerate delivery of better drugs to patients Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in genome editing, announced that its life... Read more
Posted on December 17, 2018 B&W Tek, a mobile spectroscopy solutions company that delivers lab quality Raman, LIBS, UV-Vis and NIR solutions through user-friendly mobile platforms, recently released the latest versions of their BWIQ®, BWSpec®and BWID® software packages. All of the updates were designed to provide more capabilities to users when collecting and analyzing data. BWIQ® 4.1.2BWIQ® is a comprehensive multivariate... Read more
Göttingen, December 6, 2018 – At today’s meeting, the Supervisory Board of Sartorius AG resolved to make changes in the Executive Board. Effective January 1, 2019, Dr. René Fáber as Head of the Bioprocess Solutions Division and Gerry Mackay as Head of the Lab Products & Services Division will be appointed new members of the... Read more
Suzhou, China and Cambridge, UK, December 6: Abcam plc, a global innovator in life science reagents and tools, and QIAGEN (Suzhou) Translational Medicine Co., Ltd. (QIAGEN (Suzhou)) have signed a Memorandum of Understanding (MoU) agreement to jointly develop a pipeline of Companion Diagnostic (CDx) and In Vitro Diagnostic reagents and kits, to meet the specific needs... Read more
5 December 2018 HORIBA UK Ltd. is pleased to welcome back Dr. Simon FitzGerald to its Scientific team in the role of Technical Manager. He will lead the company’s team of application and product specialists to help further HORIBA’s position as a world-leading manufacturer of spectroscopic instrumentation. Dr. FitzGerald will also work closely with users... Read more
TUE, DEC 04, 2018 07:45 CET Stockholm – Biotage AB (publ) (Biotage), (Nasdaq Stockholm: BIOT.ST) has today entered into an agreement to acquire all outstanding shares in the privately held company PhyNexus, Inc. (PhyNexus) based in California, US, for a total purchase price of approx. USD 21.5 million (corresponding to approx. SEK 195 million[1]) financed... Read more
SAN JOSE, Calif., Dec. 4, 2018 /PRNewswire/ — PhyNexus, Inc., a privately held California corporation, announces today an agreement to be acquired by Biotage AB (Nasdaq Stockholm: BIOT.ST), strengthening its position for world-wide sales and marketing of automated lab-scale purification technology of biomolecules. Together, PhyNexus and Biotage will be able to provide their global customers an enabling automation platform... Read more
MINNEAPOLIS, Dec. 4, 2018 /PRNewswire/ — Bio-Techne has further added to its cell therapy portfolio by expanding the range of Tocris Bioscience-branded cGMP small molecules to include the commonly used stem cell compounds, Y-27632 (ROCK inhibitor) and CHIR 99021. Y-27632 is a ROCK inhibitor used in stem cell cryopreservation, expansion and differentiation protocols to enhance stem cell survival... Read more